Follow the Delta-Fly Pharma 株式会社 share price and the full directors' dealings record of the company, a listed equity based in Japan. Shares are quoted on the JP market, under the oversight of EDINET (Japan FSA). Market capitalisation: €1.4bn. The latest transaction was reported on 15 November 2023 (Holding update). Among the most active insiders: NIPPON CHEMIPHAR CO., LTD.. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Delta-Fly Pharma is a company focused on the development of innovative pharmaceuticals. It is listed on the Tokyo Stock Exchange under the symbol XTKS.